tiprankstipranks
Zinzino AB Class B (SE:ZZ.B)
:ZZ.B
Want to see SE:ZZ.B full AI Analyst Report?

Zinzino AB (ZZ.B) AI Stock Analysis

5 Followers

Top Page

SE:ZZ.B

Zinzino AB

(ZZ.B)

Select Model
Select Model
Select Model
Outperform 85 (OpenAI - Gpt-5.6Sol)
Rating:85Outperform
Price Target:
kr172.00
▲(22.51% Upside)
Action:Reiterated
Date:08/27/26
The score is driven primarily by strong financial performance (healthy profitability, very low leverage, and robust free cash flow). Valuation is also supportive with a moderate P/E and solid dividend yield. Technicals are positive with the price above major moving averages, though momentum is nearing overbought (RSI ~68.5), which modestly caps the upside.
Positive Factors
Strong Revenue Growth
Strong revenue expansion indicates growing product demand and international reach. If sustained, higher scale can support distributor productivity, recurring supplement purchases and operating leverage across the business.
Negative Factors
Margin Volatility
Uneven gross margins make current profitability less predictable and complicate long-term planning. If product mix, pricing or fulfillment costs remain volatile, revenue growth may not translate consistently into durable earnings expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Strong revenue expansion indicates growing product demand and international reach. If sustained, higher scale can support distributor productivity, recurring supplement purchases and operating leverage across the business.
Read all positive factors

Zinzino AB (ZZ.B) vs. iShares MSCI Sweden ETF (EWD)

Zinzino AB Business Overview & Revenue Model

Company Description
Operating as a direct sales enterprise, Zinzino AB (publ) markets and distributes a comprehensive selection of nutritional supplements, coffee products, coffee machines, and associated accessories. The company's diverse offerings encompass health-...
How the Company Makes Money
Zinzino primarily makes money by selling health and wellness products and related test kits directly to consumers through a multi-level/direct-selling model. Revenue is generated mainly from (1) product sales of nutritional supplements (e.g., omeg...

Zinzino AB Financial Statement Overview

Summary
Overall financial quality is strong, supported by solid income performance (86), a conservatively positioned balance sheet with very low leverage and high ROE (90), and robust free cash flow with strong cash conversion to earnings (88). Key risks are margin variability across periods and some historical cash-flow volatility.
Income Statement
86
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
88
Very Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.63B3.17B2.21B1.76B1.36B1.29B
Gross Profit1.09B272.48M732.48M645.93M378.45M345.39M
EBITDA729.23M305.82M253.59M245.88M117.02M137.95M
Net Income423.29M324.32M169.17M163.74M67.70M86.20M
Balance Sheet
Total Assets2.23B1.75B1.21B842.13M651.25M605.21M
Cash, Cash Equivalents and Short-Term Investments841.99M771.00M463.05M321.24M161.88M235.73M
Total Debt62.22M41.99M46.06M61.38M49.58M38.94M
Total Liabilities1.15B1.05B818.94M578.34M490.88M453.49M
Stockholders Equity1.08B707.20M386.14M259.97M154.45M143.05M
Cash Flow
Free Cash Flow681.34M529.96M295.19M234.36M17.92M143.82M
Operating Cash Flow688.13M541.87M309.11M246.14M42.86M153.49M
Investing Cash Flow-14.75M-91.91M-98.67M-11.92M-35.42M-11.98M
Financing Cash Flow-241.13M-113.12M-68.63M-74.87M-81.28M-49.00M

Zinzino AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price140.40
Price Trends
50DMA
132.84
Positive
100DMA
133.99
Positive
200DMA
137.48
Negative
Market Momentum
MACD
2.18
Negative
RSI
52.64
Neutral
STOCH
19.49
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ZZ.B, the sentiment is Positive. The current price of 140.4 is above the 20-day moving average (MA) of 135.63, above the 50-day MA of 132.84, and above the 200-day MA of 137.48, indicating a neutral trend. The MACD of 2.18 indicates Negative momentum. The RSI at 52.64 is Neutral, neither overbought nor oversold. The STOCH value of 19.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ZZ.B.

Zinzino AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
85
Outperform
kr5.39B12.0548.04%4.64%32.85%101.50%
81
Outperform
kr16.49B18.7014.72%2.48%0.10%29.53%
63
Neutral
kr1.62B14.223.73%2.34%-2.47%460.15%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
kr3.60B44.901.16%0.66%4.84%22.61%
58
Neutral
kr107.49M13.702.02%3.50%58.41%
55
Neutral
kr2.47B-4.60-11.29%3.21%-722.98%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:ZZ.B
Zinzino AB
137.20
-28.42
-17.16%
SE:CLA.B
Cloetta AB
55.90
23.98
75.10%
SE:MSON.B
Midsona AB Class B
10.95
3.05
38.61%
SE:SECARE
Swedencare AB
22.45
-16.64
-42.57%
SE:HUMBLE
Humble Group AB
5.57
-2.54
-31.32%
SE:NNH
New Nordic Healthbrands AB
17.40
-6.12
-26.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 27, 2026